Form 4 for DRMA Dermata Therapeutics, Inc.
Accepted 2022-04-08 00:00:00 ET · period of report 2022-04-07 · accession 0000905718-22-000572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-08 | 2022-04-07 | DRMA | WIERENGA WENDELL | Dir | A - Grant | $0.00 | +10.6K | 15.5K | +217% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-07 | A | A | 10,593 | $0.00 | 15,471 | D | — | — | (F1) On April 7, 2022, the Reporting Person was granted 10,593 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan. |